Clinical Trials Browser

Neoplasms × folfirinox × Tumor-Agnostic × Clear all

NCT02178709 2022-04-19

A Phase II Study of Neoadjuvant FOLFIRINOX

Phase 2 Completed

48 enrolled 16 charts

Neoplasms